Skip to main content
Year archive

Everest Medicines Limited — 2020 filings

All 25 regulatory filings released by Everest Medicines Limited (1952) in 2020, sourced directly from the official regulator.

25 Filings
2020 Period
2020 filings (25)
Filing Released Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-12-22 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-12-22 English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON FIRST PATIENT DOSED IN PHASE 3 REGISTRATION ASIAN STUDY OF TRODELVY (SACITUZUMAB GOVITECAN) FOR HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE METASTATIC BREAST CAN
Regulatory Filings
2020-12-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended November 30, 2020
Share Issue/Capital Change
2020-12-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended October 31, 2020
Share Issue/Capital Change
2020-12-04 English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON RECOMMENDED BREAKTHROUGH THERAPY DESIGNATION FOR NEFECON FOR THE TREATMENT OF IGA NEPHROPATHY
Regulatory Filings
2020-12-02 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON LICENSING PARTNER CALLIDITAS THERAPEUTICS REPORTING TOPLINE RESULTS FROM PIVOTAL PHASE 3 NEFIGARD TRIAL
Regulatory Filings
2020-11-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Share Issue/Capital Change
2020-11-06 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE OF FIRST PATIENT DOSED IN PHASE 2B REGISTRATION CLINICAL TRIAL OF TRODELVY (SACITUZUMAB GOVITECAN) FOR THE TREATMENT OF METASTATIC TRIPLE-NEGATIVE BREAST CANCE
Regulatory Filings
2020-11-03 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON APPROVAL OF CLINICAL TRIAL APPLICATION BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR PHASE 3 REGISTRATION TRIAL OF TRODELVY FOR METASTATIC BREAST CA
Regulatory Filings
2020-11-02 English
FULL EXERCISE OF OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
Capital/Financing Update
2020-11-01 English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE COMPLETION OF PHASE 3 BRIDGING CLINICAL TRIAL OF XERAVATM (ERAVACYCLINE) FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN CHINA
Regulatory Filings
2020-10-27 English
List of Directors and Their Role and Function
Board/Management Information
2020-10-08 English
Terms of Reference of the Nomination Committee
Governance Information
2020-10-08 English
Terms of Reference of the Remuneration Committee
Remuneration Information
2020-10-08 English
Terms of Reference of the Audit Committee
Governance Information
2020-10-08 English
Amended and Restated Memorandum and Articles of Association
Governance Information
2020-10-08 English
Announcement of Offer Price and Allotment Results
Regulatory Filings
2020-10-08 English
GREEN APPLICATION FORM
Capital/Financing Update
2020-09-25 English
GLOBAL OFFERING
Share Issue/Capital Change
2020-09-25 English
GLOBAL OFFERING
Capital/Financing Update
2020-09-25 English
PHIP (1st submission)
Audit Report / Information FY 2019
2020-09-20 English
PHIP (1st submission)
Regulatory Filings
2020-09-20 English
Application Proof (1st submission)
Audit Report / Information FY 2019
2020-07-19 English
Application Proof (1st submission)
Capital/Financing Update
2020-07-19 English